Project Grant HT94252510046
Award Date
2/1/25
Completion Date
1/31/27
Dollars Obligated
$389K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Australia
Similar Awards
The University of Melbourne received a $1,109,929 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to develop a neurotrophin therapy for clinical translation. The grant, awarded on September 1, 2024, will support research aimed at improving health outcomes for military service members, veterans, and the broader public by advancing innovative treatments for neurological disorders. The three-year project will...
The University of Melbourne was awarded a $591,778 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) to conduct research aimed at "Harnessing the Immune Response in Exceptionally Long-Term Survivors to Develop Novel Therapeutics." The project will run from May 1, 2024 to April 30, 2027. The University of Melbourne has a history of conducting federal research and consulting work in areas such as...
This federal Project Grant award in the amount of $733,068.00 was issued by the Defense Health Agency to the University of Melbourne on September 1, 2023 under the Military Medical Research and Development program (CFDA 12.420). The funding will support a 3-year research project titled "Investigating Transcript Diversity as a Driver of Melanoma Progression and Recurrence." The University of Melbourne will conduct basic, translational, and clinical research aimed at developing new...
The Defense Health Agency awarded a $4,319,388 Project Grant to the University of Melbourne to fund research aimed at "TARGETING SENESCENT CELLS TO IMPROVE OUTCOMES FOR BREAST CANCER PATIENTS" over the period from September 1, 2024 to August 31, 2028. This grant is provided under the Military Medical Research and Development Program (CFDA 12.420), which supports biomedical research to improve the health and care of military service members, veterans, and their families. The...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $968,717 to the University of Melbourne in Australia to conduct research aimed at solving a major complication of Parkinson's disease - debilitating constipation - through novel pharmacology. The research project will run from April 2025 to April 2028, targeting innovative solutions to address this significant health challenge for military service members and...
The University of Melbourne was awarded an $854,195 project grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will support integrative molecular characterization and biomarker validation research in metastatic hormone-sensitive prostate cancer from September 2021 through August 2025. Through this funding, the University of Melbourne will conduct basic, applied, and advanced biomedical research to investigate medical...
The University of Melbourne was awarded a $768,263 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will fund research on developing a novel inhibitor of ribosome biogenesis with antitumor activity in preclinical models of prostate cancer. The goal of the Military Medical Research and Development program is to transform military and public health through innovative medical research solutions. This award will...
The University of Melbourne was awarded a $369,855.64 Project Grant from the Defense Health Agency under the Military Medical Research and Development Program (CFDA 12.420) to conduct research on "Piecing the Puzzle Together: Unraveling the Genomic Landscape of Low-Grade Serous Ovarian Carcinoma (LGSOC) to Guide Novel Therapeutic Strategies." This 2-year grant, running from Sep 1, 2023 to Aug 31, 2025, will support the university's efforts to advance the understanding of low-grade...
The University of Sydney was awarded a $632,080 project grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, awarded on July 1, 2025, will support research investigating "What endows women with a better chance of survival from melanoma?" over a project period ending on June 30, 2028. This research aims to transform healthcare for military service members, veterans, and the broader public by advancing...
The University of Queensland in Australia was awarded a $744,744 USD project grant from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project titled "Understanding the Role of Immature Myeloid Cells in Early Melanoma Establishment" from September 30, 2022 to September 29, 2025. Through this funding, researchers at The University of Queensland will investigate the role of immature myeloid...